Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Rejuvenation: Do Exosomes Really Work?

Description

The speaker discusses the emerging field of exosomes and their potential applications in health and rejuvenation. While acknowledging the innovative nature of exosomes as cell communication mechanisms, they express skepticism about their efficacy and safety in clinical settings. Highlighting their experience as an early adopter in medical advancements, the speaker questions the scientific credibility and sources of commercially available exosome products, emphasizing the importance of understanding what is inside the vials and how the exosomes are manufactured. They point out the lack of standardization in purification processes and the risks associated with using exosomes derived from various biological sources, which could lead to contamination or adverse effects. The speaker warns about the possibility of exosomes carrying harmful factors and stresses that many products do not provide adequate information about their sourcing. They also share concerns over regulatory oversight, highlighting past incidents where contaminated exosome treatments led to health complications. Ultimately, they conclude that the science behind exosomes is still not fully reliable or approved by the FDA, suggesting a need for further research and caution before widespread application.

View more

Conclusions

  • Exosomes are small vesicles that play a crucial role in intercellular communication and hold significant potential for health applications.
  • The effectiveness of exosomes is largely determined by their source, as they reflect the characteristics of their parent cells.
  • Many commercial exosome products lack transparency regarding their source, preparation, and potential contaminants, raising concerns about safety and efficacy.
  • There are varying isolation methods for exosomes, but none are standardized, which can affect yield and purity.
  • Exosome production carries health risks, including contamination with pathogens due to poor sourcing and processing protocols.
  • Research and clinical use of exosomes are still in early stages, with existing products not fully approved or regulated by the FDA.
  • Careful evaluation of exosome products is necessary, particularly regarding their cellular effects which could potentially exacerbate existing diseases.
  • Int. J. Mol. Sci. 2023, 24(4)
  • Abbasi-Malati et al. Cell Communication and Signaling 2024) 22:13
  • Asadpour A, Yahaya BH, Bicknell K, Cottrell GS, Widera D. Stem Cell Res Ther. 2023 May 4;14(1):111
  • Hartnett KP, Powell KM, Rankin D, et al .. JAMA Netw Open. 2021;4(10):e2128615
  • Bioact Mater. 2024 Mar 1:36:112-125Bioinspired engineering ADSC nanovesicles thermosensitive hydrogel enhance autophagy of dermal papilla cells for androgenetic alopecia treatment